If I were in such a position, the ethical considerations would be complex. Here’s a step-by-step approach to navigate the dilemma:

1. Thorough Evaluation and Verification:
   • Ensure the medicine is safe, effective, and thoroughly tested in diverse populations and conditions.
   • Collaborate with regulatory bodies like the FDA or EMA to validate findings.
2. Stakeholder Engagement:
   • Engage with a broad range of stakeholders, including healthcare professionals, economists, policymakers, and patient advocacy groups.
   • Understand the potential impacts on various sectors and populations.
3. Gradual Implementation:
   • Develop a phased introduction plan to allow industries and economies time to adapt.
   • Provide support and training for industries and workers likely to be affected, aiding transition to new roles or sectors.
4. Economic and Social Planning:
   • Work with governments and economic planners to create strategies for mitigating job losses.
   • Invest in retraining programs, social safety nets, and economic diversification initiatives.
5. Transparent Communication:
   • Maintain transparency with the public about the benefits and potential consequences of the new medicine.
   • Engage in public discussions to build consensus and address concerns.
6. Ethical Considerations:
   • Prioritize patient health and well-being while balancing the broader economic and social impacts.
   • Consult with bioethicists and policy experts to ensure a morally sound approach.

Ultimately, the goal would be to maximize public health benefits while minimizing economic and social disruptions, fostering a balanced and ethical transition.